This present disclosure relates to series compounds and methods of use for the treatment of a disease caused by abnormal regulation of the ubiquitin-proteasome system (UPS), and wherein said compound is an effective stimulator of the 20S core particle (CP) of the UPS. Composition matters and methods of uses are within the scope of this disclosure.
本公开涉及一系列化合物及其治疗由于泛素-
蛋白酶体系统(
UPS)异常调节引起的疾病的方法,其中所述化合物是
UPS的20S核心粒子(CP)的有效刺激剂。本公开范围内涉及组成物和使用方法。